Epidemiology and Prevalence of Dyslipidemia Among Adult Population of Tehran: The Tehran Cohort Study.

22 , 23 A previous study has demonstrated a favorable trend in reducing TC and non-HDL-C from 1999 to 2011 in Tehran; however, it was limited due to the small sample size and single-district sampling. 24 Since then, no other study has evaluated the prevalence of dyslipidemia in Tehran, and its current net prevalence remains unknown.

also in 559 other papers

2 - 4 The global burden of dyslipidemia showed an increasing trend due to the aging population, inadequate physical activity, behavioral risk factors, and obesity, particularly in developing countries. 1 , 5 In 2015, Iran was the third most affected country in the Eastern-Mediterranean region with 54.1% prevalence of hypercholesterolemia and recorded 46% of CVD de

also in 27,205 other papers